Patents Assigned to USV Private Limited
  • Process for preparation of regadenoson and polymorphs thereof
    Patent number: 10815265
    Abstract: The present invention relates to a process for preparation of Regadenoson and polymorphs thereof. In particular, the present invention relates to a process for preparation of Regadenoson Form C.
    Type: Grant
    Filed: June 27, 2019
    Date of Patent: October 27, 2020
    Assignee: USV Private Limited
    Inventors: Laxmikant Narhari Patkar, Kamlesh Digambar Sawant, Harish Kashinath Mondkar, Tushar Anil Naik
  • Synthesis of dabigatran
    Patent number: 9688657
    Abstract: The present invention relates to a process for preparation of Dabigatran etexilate or pharmaceutically acceptable salt thereof. The present invention relates to novel compounds, in particular Ethyl-3-{[(2-formyl-1-methyl-1H-benzimidazole-5-yl)carbonyl]-(2-pyridinyl) amino}propanoate and Ethyl-3-{[(2-dichloromethyl-1-methyl-1H-benzimidazole-5-yl)carbonyl]-(2-pyridinyl)amino}propanoate and process for preparation thereof. The present invention further relates to the use of these novel compounds in the preparation of Dabigatran etexilate or pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: March 25, 2014
    Date of Patent: June 27, 2017
    Assignee: USV Private Limited
    Inventors: Laxmikant Narhari Patkar, Harish Kashinath Mondkar, Nitin Dnyaneshwar Arote, Sachin Shivaji Patil, Tanaji Shamrao Jadhav, Nitin Nivrutti Hagavane, Rajesh Ganpat Bhopalkar